Budget Impact Analysis Of Subcutaneous Belimumab In Patients With Systemic Lupus Erythematosus In Spain

OBJECTIVE: To evaluate the budget impact and the direct costs of the introduction of subcutaneous belimumab (SC) into the Spanish National Health Service (NHS) for patients with systemic lupus erythematosus (SLE) in Spain. METHODS: This study was conducted from the Spanish NHS perspective with a tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Cevey, Maria, Calvo-Alén, Jaime, Crespo, Carlos, Robles-Marhuenda, Angel, Smolen, Lee, Cortés-Hernández, Josefina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901000/
https://www.ncbi.nlm.nih.gov/pubmed/31824182
http://dx.doi.org/10.2147/CEOR.S218464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901000/
https://www.ncbi.nlm.nih.gov/pubmed/31824182
http://dx.doi.org/10.2147/CEOR.S218464

Ejemplares similares